Keros Therapeutics, Inc. (KROS)
19.40
+0.38
(+2.00%)
USD |
NASDAQ |
Jan 22, 12:48
Keros Therapeutics Free Cash Flow: 87.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| MannKind Corp. | 42.74M |
| Insmed, Inc. | -906.14M |
| Innoviva, Inc. | 196.54M |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.249M |
| Cash from Investing (Quarterly) | -0.132M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow Per Share (Quarterly) | 0.0767 |
| Free Cash Flow to Equity (Quarterly) | 3.642M |
| Free Cash Flow to Firm (Quarterly) | 3.117M |
| Free Cash Flow Yield | 11.04% |